Toggle light / dark theme

The divide between their lineage and ours narrowed even further in 2010, when researchers published the first Neandertal genome sequence. Comparison of that ancient DNA with modern human DNA showed that the two species had interbred and that people today still carry the genetic fingerprint of that intermixing. Since then, numerous studies have explored the ways in which Neandertal DNA affects our modern physiology, revolutionizing our understanding not only of our extinct cousins but of ourselves as a hybrid species.

This area of research, clinical paleogenomics, is still in its infancy, and there are many complexities to unravel as we explore this new frontier. We therefore must take the findings from these studies with a grain of salt. Nevertheless, the research conducted to date raises the fascinating possibility that Neandertal DNA has wide-­reach­ing effects on our species—not only on general health but on brain development, including our propensity for conditions such as autism. In other words, DNA from our extinct relatives may, to some extent, shape the cognition of people today.

This old talk by Daniel Dennett touches on a lot of topics we’ve discussed recently. Dennett explains why it’s wrong to regard phenomenal consciousness (the “what it’s likeness” or “raw experience” version) as separate from access consciousness (the cognitive access of information for decision making, memory, report, etc).

Note that Dennett doesn’t deny the existence of phenomenal consciousness here, just the idea that it’s something separate and apart from access. He even passes up opportunities to dismiss qualia, although he does provide a reduction of them.

This video is about 66 minutes long. Unfortunately the video and sound quality aren’t great, and the camera operation is annoying, but the talk is worth powering through.

Attention schema theory has some plausibility.


Lately I’ve been reading up on global workspace theory (GWT). In a survey published last year, among general consciousness enthusiasts, integrated information theory (IIT) was the most popular theory, followed closely by GWT. However, among active consciousness researchers, GWT was seen as the most promising by far (although no theory garnered a majority). Since seeing those results, I’ve been curious about why.

One reason might be that GWT has been around a long time, having first been proposed by Bernard Baars in 1988, with periodic updates all recently republished in his new book. It’s received a lot of development and has spawned numerous variants. Daniel Dennett’s multiple drafts model is one. But perhaps the one with the most current support is Stanislas Dehaene’s global neuronal workspace, which I read and wrote about earlier this year.

All of the variants posit that for an item to make it into consciousness, it has to enter a global workspace in the brain. This is most commonly described using a theater metaphor.

New research from the Academy of Military Medical Sciences in Beijing has uncovered a rather intriguing finding: natural melanin nanozymes (NMNs) derived from octopus ink may potentially slow ageing, protect against neurodegenerative diseases, and extend lifespan. Published in ACS Omega, the study reveals how these nanozymes work at the cellular level to mitigate oxidative stress, improve gut health, and enhance brain function, offering a new frontier in anti-ageing and neurological research.

What are Melanin Nanozymes?

Melanin, best known as the pigment responsible for skin and hair colour, has also been recognized for its potent antioxidant properties. Nanozymes created from natural melanin, like those extracted from octopus ink, mimic the activity of antioxidant enzymes such as superoxide dismutase (SOD). These nanozymes neutralize free radicals, reduce oxidative stress, and improve cellular health—processes that are critical in mitigating ageing and the onset of neurodegenerative diseases.

Daniel Dennett might be closer to truth on consciousness.


Full Episode: https://www.youtube.com/watch?v=kMxTS7eKkNM
Title: “Michael Levin: What Is The Field Of Diverse Intelligence (DI)? All Possible Intelligent Agents”

CONNECT:
- Website: https://tevinnaidu.com.
- Podcast: https://podcasters.spotify.com/pod/show/drtevinnaidu.
- Twitter: https://twitter.com/drtevinnaidu.
- Facebook: https://www.facebook.com/drtevinnaidu.
- Instagram: https://www.instagram.com/drtevinnaidu.
- LinkedIn: https://www.linkedin.com/in/drtevinnaidu.

Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

#MichaelLevin #Consciousness #MindBodyProblem #Panpsychism

Participants underwent fMRI while completing a monetary incentive delay task. This task is commonly used to assess reward system activation, as it separates the anticipation of a reward from the receipt of the reward. During the task, participants viewed visual cues signaling whether they could win money or not. They were then required to press a button quickly in response to a target, with feedback indicating whether they had succeeded in earning the reward.

The study focused on two key brain regions: the ventral striatum, which is involved in reward anticipation, and the orbitofrontal cortex, which processes reward outcomes. Psychological resilience was measured using the Connor-Davidson Resilience Scale, while PTSD severity was assessed with the Clinician-Administered PTSD Scale. Metabolic syndrome was diagnosed based on established clinical criteria, including elevated blood pressure, abnormal cholesterol or triglyceride levels, elevated blood sugar, and increased waist circumference.

The researchers observed distinct patterns of reward system activation in individuals with PTSD, influenced by the severity of depressive symptoms. Among PTSD participants with lower depression severity, activation in the ventral striatum during reward anticipation was reduced, while activation in the orbitofrontal cortex during reward outcomes was heightened.

New Science Advances research in mice reveals that immune cells in the brain engulf microplastics, forming clusters that can cause cerebral clots.

The human brain is formed by a complex network of neural connections and most of them link neighboring brain regions, which are also the most studied to date. But a recent neuroscientific study by Pompeu Fabra University (UPF) and the University of Oxford, published in Proceedings of the National Academy of Sciences, has revealed that connections between distant brain regions, though rarer and less frequent, play a fundamental role in explaining brain dynamics.

The role of these long-range connections could be likened to those of an airport hub, which—with long-haul flights—directly connects different parts of the world without the need for stopovers, which would make the trip far longer. In the case of the brain, long-range connections serve to transmit information more quickly and directly between distant regions (without the need to go through all the successive neighboring regions that separate them). This yields optimal and efficient information processing.

The connections between distant regions of the brain are activated both spontaneously in a resting state and when performing numerous cognitive functions in our daily lives, which allow us to carry out specific tasks. For example, for as simple a task as remembering an image we have just seen, the brain connects the (which deals with ) with the occipital lobe, which deals with image perception.

A study by the University of the Basque Country (UPV/EHU) demonstrates that the drug WIN55,212–2 protects the brain and reverses early cognitive damage caused by dementia, while also explaining its mechanism of action.

Over two decades of research conducted by the Neurochemistry and Neurodegeneration group at UPV/EHU, led by Dr. Rafael Rodríguez-Puertas, has uncovered a promising pathway for developing therapies aimed at improving memory in cases of cognitive impairment caused by neurodegenerative diseases like Alzheimer’s.

Alzheimer’s disease is a progressive neurological disorder that primarily affects older adults, leading to memory loss, cognitive decline, and behavioral changes. It is the most common cause of dementia. The disease is characterized by the buildup of amyloid plaques and tau tangles in the brain, which disrupt cell function and communication. There is currently no cure, and treatments focus on managing symptoms and improving quality of life.

A research team at KAIST has identified the core gene expression networks regulated by key proteins that fundamentally drive phenomena such as cancer development, metastasis, tissue differentiation from stem cells, and neural activation processes. This discovery lays the foundation for developing innovative therapeutic technologies.

A joint research team led by Professors Seyun Kim, Gwangrog Lee, and Won-Ki Cho from the Department of Biological Sciences has uncovered essential mechanisms controlling gene expression in animal cells.

The findings were published on January 7 in the journal Nucleic Acids Research in a paper titled “Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF.”